Formation of adeno-associated virus circular genomes is differentially regulated by adenovirus E4 ORF6 and E2a gene expression

被引:68
作者
Duan, DS
Sharma, P
Dudus, L
Zhang, YL
Sanlioglu, S
Yan, ZY
Yue, YP
Ye, YH
Lester, R
Yang, J
Fisher, KJ
Engelhardt, JF
机构
[1] Univ Iowa, Sch Med, Dept Anat & Cell Biol, Iowa City, IA 52242 USA
[2] Univ Iowa, Sch Med, Dept Internal Med, Iowa City, IA 52242 USA
[3] Tulane Univ, Med Ctr, Dept Pathol & Lab Med, New Orleans, LA 70118 USA
关键词
D O I
10.1128/JVI.73.1.161-169.1999
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
A central feature of the adeno-associated virus (AAV) latent life cycle is persistence in the form of both integrated and episomal genomes. However, the molecular processes associated with episomal long-term persistence of AAV genomes are only poorly understood, To investigate these mechanisms, we have utilized a recombinant AAV (rAAV) shuttle vector to identify circular AAV intermediates from transduced HeLa cells and primary fibroblasts. The unique structural features exhibited by these transduction intermediates included circularized monomer and dimer virus genomes in a head-to tail array, with associated specific base pair alterations in the 5' viral D sequence. In HeLa cells, the abundance and stability of AAV circular intermediates were augmented by adenovirus expressing the E2a gene product. In the absence of E2a, adenovirus expressing the E4 open reading frame 6 gene product decreased the abundance of AAV circular intermediates, favoring instead the linear replication form monomer (Rf(m)) and dimer (Rf(d)) structures. In summary, the formation of AAV circular intermediates appears to represent a new pathway for AAV genome conversion, which is consistent with the head-to-tail concatemerization associated with latent-phase persistence of rAAV, A better under standing of this pathway may increase the utility of rAAV vectors for gene therapy.
引用
收藏
页码:161 / 169
页数:9
相关论文
共 30 条
[1]   In vivo model of adeno-associated virus vector persistence and rescue [J].
Afione, SA ;
Conrad, CK ;
Kearns, WG ;
Chunduru, S ;
Adams, R ;
Reynolds, TC ;
Guggino, WB ;
Cutting, GR ;
Carter, BJ ;
Flotte, TR .
JOURNAL OF VIROLOGY, 1996, 70 (05) :3235-3241
[2]  
Bennett J, 1997, INVEST OPHTH VIS SCI, V38, P2857
[3]  
BERNS KI, 1996, ADENO ASS VIRUS AAV
[4]  
Conrad CK, 1996, GENE THER, V3, P658
[5]   Circular intermediates of recombinant adeno-associated virus have defined structural characteristics responsible for long-term episomal persistence in muscle tissue [J].
Duan, DS ;
Sharma, P ;
Yang, JS ;
Yue, YP ;
Dudus, L ;
Zhang, YL ;
Fisher, KJ ;
Engelhardt, JF .
JOURNAL OF VIROLOGY, 1998, 72 (11) :8568-8577
[6]   Structural and functional heterogeneity of integrated recombinant AAV genomes [J].
Duan, DS ;
Fisher, KJ ;
Burda, JF ;
Engelhardt, JF .
VIRUS RESEARCH, 1997, 48 (01) :41-56
[7]   Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors [J].
Ferrari, FK ;
Samulski, T ;
Shenk, T ;
Samulski, RJ .
JOURNAL OF VIROLOGY, 1996, 70 (05) :3227-3234
[8]   Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis [J].
Fisher, KJ ;
Gao, GP ;
Weitzman, MD ;
DeMatteo, R ;
Burda, JF ;
Wilson, JM .
JOURNAL OF VIROLOGY, 1996, 70 (01) :520-532
[9]   ADENOASSOCIATED VIRUS VECTOR GENE-EXPRESSION OCCURS IN NONDIVIDING CELLS IN THE ABSENCE OF VECTOR DNA INTEGRATION [J].
FLOTTE, TR ;
AFIONE, SA ;
ZEITLIN, PL .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1994, 11 (05) :517-521
[10]   Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus [J].
Herzog, RW ;
Hagstrom, JN ;
Kung, SH ;
Tai, SJ ;
Wilson, JM ;
Fisher, KJ ;
High, KA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (11) :5804-5809